These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33308233)

  • 1. Heart failure documentation in outpatients with diabetes and volume overload: an observational cohort study from the Diabetes Collaborative Registry.
    Arnold SV; Jones PG; Beasley M; Cordova J; Goyal A; Fonarow GC; Seman L
    Cardiovasc Diabetol; 2020 Dec; 19(1):212. PubMed ID: 33308233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of glucose-lowering medication use in patients with type 2 diabetes and heart failure. Insights from the Diabetes Collaborative Registry (DCR).
    Arnold SV; Echouffo-Tcheugui JB; Lam CSP; Inzucchi SE; Tang F; McGuire DK; Goyal A; Maddox TM; Sperling LS; Fonarow GC; Masoudi FA; Kosiborod M
    Am Heart J; 2018 Sep; 203():25-29. PubMed ID: 30015065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and incidence of heart failure in type 2 diabetes patients: results from a nationwide prospective cohort-the DIABET-IC study.
    Gonzalez-Manzanares R; Anguita-Gámez M; Muñiz J; Barrios V; Gimeno-Orna JA; Pérez A; Rodríguez-Padial L; Anguita M;
    Cardiovasc Diabetol; 2024 Jul; 23(1):253. PubMed ID: 39014420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation Into Potentially Inappropriate Prescribing Patterns of Loop Diuretics in a Nationally Representative Outpatient Population.
    Fosnight S; Soric MM; Smearman J; Graves E; Vazquez M; Herrington Z; Palladino C; Costello M; Knauss A
    Am J Ther; 2024 Jul-Aug 01; 31(4):e347-e355. PubMed ID: 37820082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 Diabetes Mellitus and Impact of Heart Failure on Prognosis Compared to Other Cardiovascular Diseases: A Nationwide Study.
    Zareini B; Blanche P; D'Souza M; Elmegaard Malik M; Nørgaard CH; Selmer C; Gislason G; Kristensen SL; Køber L; Torp-Pedersen C; Schou M; Lamberts M
    Circ Cardiovasc Qual Outcomes; 2020 Jul; 13(7):e006260. PubMed ID: 32571092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart failure labelled patients with missing ejection fraction in primary care: prognosis and determinants.
    Muñoz MA; Mundet-Tuduri X; Real J; Del Val JL; Domingo M; Vinyoles E; Calero E; Checa C; Soldevila-Bacardit N; Verdú-Rotellar JM
    BMC Fam Pract; 2017 Mar; 18(1):38. PubMed ID: 28302060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes in patients treated with loop diuretics without a diagnosis of heart failure: a retrospective cohort study.
    Cuthbert JJ; Soyiri I; Lomax SJ; Turgoose J; Fuat A; Cohen J; Clark AL
    Heart; 2024 May; 110(12):854-862. PubMed ID: 38631899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms and prediction of short-term natriuretic effect of sodium-glucose cotransporter 2 inhibitor in heart failure patients coexisting type 2 diabetes mellitus.
    Fukuoka S; Dohi K; Takeuchi T; Moriwaki K; Ishiyama M; Omori T; Fujimoto N; Ito M
    Heart Vessels; 2020 Sep; 35(9):1218-1226. PubMed ID: 32270357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are there patients missing from community heart failure registers? An audit of clinical practice.
    Cuthbert JJ; Gopal J; Crundall-Goode A; Clark AL
    Eur J Prev Cardiol; 2019 Feb; 26(3):291-298. PubMed ID: 30396291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loop diuretic use at discharge is associated with adverse outcomes in hospitalized patients with heart failure: a report from the Japanese cardiac registry of heart failure in cardiology (JCARE-CARD).
    Hamaguchi S; Kinugawa S; Tsuchihashi-Makaya M; Goto D; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H;
    Circ J; 2012; 76(8):1920-7. PubMed ID: 22665070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit.
    Buckley LF; Carter DM; Matta L; Cheng JW; Stevens C; Belenkiy RM; Burpee LJ; Young MA; Weiffenbach CS; Smallwood JA; Stevenson LW; Desai AS
    JACC Heart Fail; 2016 Jan; 4(1):1-8. PubMed ID: 26656139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) Profiling Identifies Ambulatory Patients at High Risk on Medical Therapy After Hospitalizations for Heart Failure.
    Stewart GC; Kittleson MM; Patel PC; Cowger JA; Patel CB; Mountis MM; Johnson FL; Guglin ME; Rame JE; Teuteberg JJ; Stevenson LW
    Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27834198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF.
    Yancy CW; Fonarow GC; Albert NM; Curtis AB; Stough WG; Gheorghiade M; Heywood JT; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
    Am Heart J; 2009 Apr; 157(4):754-62.e2. PubMed ID: 19332206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry.
    Brunner-La Rocca HP; Linssen GC; Smeele FJ; van Drimmelen AA; Schaafsma HJ; Westendorp PH; Rademaker PC; van de Kamp HJ; Hoes AW; Brugts JJ;
    JACC Heart Fail; 2019 Jan; 7(1):13-21. PubMed ID: 30606482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors, outcomes and healthcare utilisation in individuals with multimorbidity including heart failure, chronic kidney disease and type 2 diabetes mellitus: a national electronic health record study.
    Pasea L; Dashtban A; Mizani M; Bhuva A; Morris T; Mamza JB; Banerjee A
    Open Heart; 2023 Sep; 10(2):. PubMed ID: 37758654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guideline-Directed Medication Use in Patients With Heart Failure With Reduced Ejection Fraction in India: American College of Cardiology's PINNACLE India Quality Improvement Program.
    Pokharel Y; Wei J; Hira RS; Kalra A; Shore S; Kerkar PG; Kumar G; Risch S; Vicera V; Oetgen WJ; Deswal A; Turakhia MP; Glusenkamp N; Virani SS
    Clin Cardiol; 2016 Mar; 39(3):145-9. PubMed ID: 26880649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Analysis of Long-Term Outcomes of Torasemide and Furosemide in Heart Failure Patients in Heart Failure Registries of the European Society of Cardiology.
    Ozierański K; Balsam P; Kapłon-Cieślicka A; Tymińska A; Kowalik R; Grabowski M; Peller M; Wancerz A; Marchel M; Crespo-Leiro MG; Maggioni AP; Drożdż J; Filipiak KJ; Opolski G
    Cardiovasc Drugs Ther; 2019 Feb; 33(1):77-86. PubMed ID: 30649675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Heart Failure Medical Therapies Among Patients With Left Ventricular Assist Devices: Insights From INTERMACS.
    Khazanie P; Hammill BG; Patel CB; Kiernan MS; Cooper LB; Arnold SV; Fendler TJ; Spertus JA; Curtis LH; Hernandez AF
    J Card Fail; 2016 Sep; 22(9):672-9. PubMed ID: 26892975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discharge Diuretic Dose and 30-Day Readmission Rate in Acute Decompensated Heart Failure.
    Woodruff AE; Kelley AM; Hempel CA; Loeffler WJ; Echtenkamp CA; Hassan AK
    Ann Pharmacother; 2016 Jun; 50(6):437-45. PubMed ID: 26956954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signs, symptoms, and treatment patterns across serial ambulatory cardiology visits in patients with heart failure: insights from the NCDR PINNACLE® registry.
    Allen LA; Tang F; Jones P; Breeding T; Ponirakis A; Turner SJ
    BMC Cardiovasc Disord; 2018 May; 18(1):80. PubMed ID: 29724164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.